M. NURHIDAYAH, F. FADILAH, A. ARSIANTI, and A. BAHTIAR, “IDENTIFICATION OF FGFR INHIBITOR AS ST2 RECEPTOR/INTERLEUKIN-1 RECEPTOR-LIKE 1 INHIBITOR IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE DUE TO EXPOSURE TO E-CIGARETTES BY NETWORK PHARMACOLOGY AND MOLECULAR DOCKING PREDICTION”, Int J App Pharm, vol. 14, no. 2, pp. 256–266, Mar. 2022.